about
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimeti...
Read More
16.76
-0.05
(-0.30%)
199.0K
XNAS Volume
XNAS 09 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
GlycoMimetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..